Healthcare / Medical Instruments & Supplies

The Cooper Companies, Inc. (COO)

$59.49
-1.16%
$11.9B
Market Cap
30.5
P/E Ratio
0.89
Beta
Dividend Yield
Piotroski 5/9Altman Z 3.5 SafeBeneish M -2.49 CleanROIC−WACC -5.7%

Quantitative Summary

Deterministic

At 30.5x earnings — a 53% discount to the sector average of 65.2x — COO is in the lower valuation range. Financial health is average: Piotroski 5/9, Altman Z 3.5. DCF fair value of $28 implies 61% downside based on model assumptions.

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of The Cooper Companies reveal a significant capital allocation challenge, as the return on invested capital stands at 4.7%, trailing markedly behind the estimated cost of equity at 10.1%. This results in a negative spread of -5.4%, indicating that current operations are eroding shareholder value rather than generating excess returns. While the DuPont decomposition highlights healthy operating leverage with net margins expanding to 9.2% and robust gross margins near 65.5%, this profitability is constrained by low asset turnover at only 0.33x, suggesting inefficient capital deployment relative to sales volume. The equity multiplier of 1.50x provides modest financial leverage but does not offset the core inefficiency in generating returns on assets.

Valuation metrics present a mixed picture where market pricing appears detached from intrinsic value models derived from free cash flow assumptions. Despite trading at a forward P/E multiple of 34.9x, which remains slightly below the sector average of 36.8x, the discounted cash flow analysis implies substantial downside potential with a fair value estimate significantly lower than current levels. This divergence suggests the market is pricing in an aggressive ten-year free cash flow growth rate of 17.2%, a trajectory that may be overly optimistic given the underlying capital efficiency constraints. The Beneish M-Score of -2.49 offers some comfort regarding earnings quality, yet the Piotroski F-Score of 5/9 and Altman Z-Score of 3.5 indicate moderate financial stability without strong momentum indicators.

Risk-adjusted performance data further complicates the investment thesis, with a negative annualized Fama-French alpha of -14.39% signaling underperformance relative to standard risk factors over time. While the stock exhibits neutral exposure to both value and profitability factor tilts, the persistent negative alpha suggests that historical returns have failed to compensate for the systematic risks taken. With no discernible insider buying activity over the last ninety days, there is currently a lack of private capital signaling confidence in near-term catalysts to bridge the gap between current valuations and intrinsic worth implied by conservative cash flow models.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive
Market Price
$59.49
Fair Value
$27
Implied Upside
-53.8%
$27IMPLIED FAIR VALUEOVERVALUEDOVERUNDER
Growth Rate (Y1–5)9%
-10%20%50%
Discount Rate (WACC)10.3%
5%12.5%20%

5-year two-stage DCF. Terminal growth 3%. Default sliders match the pre-computed base case. Drag to explore scenarios. Not investment advice.

Reverse DCFMarket-Implied
17.7%annual FCF growth priced in at $59.49

The growth rate the market implicitly expects over the next 10 years to justify today's price. Compare with historical growth of 5% YoY revenue.

Sensitivity Matrix

TG ↓ / WACC →8.3%10.3%12.3%
2%$36$24$17
3%$43$28$19
4%$54$33$22

Center = base case. Green = >10% upside, Red = >10% downside vs $59.49.

Pre-computed DCF: WACC=10.3%, terminal growth 3%. Fair value $28 (-61.1%). Not investment advice.

Valuation Context

30.5x
COO P/E
65.2x
Sector Avg
43.4x
5Y Avg P/E
-53%
vs Sector

Currently trading 18% below its 5-year average P/E of 43.4x.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Technical Setup

AI Generated

The Cooper Companies, Inc. is currently trading at $60.94 within the healthcare sector, presenting a specific context for evaluating its relative valuation against moving average envelopes. Without explicit data regarding the precise location of short-term or long-term Simple Moving Averages in relation to this current price point, any assessment of mean-reversion potential remains hypothetical rather than definitive. Typically, when a stock trades significantly outside an established SMA envelope, it suggests a deviation from its recent historical trend line that might eventually trigger a pullback toward the center; conversely, trading near or within the bands often indicates stability with limited immediate directional pressure. In this instance, the absence of specific band placement data prevents a conclusive determination regarding whether the $60.94 level represents an overextended condition ripe for correction or a stable equilibrium zone. Observers might note that if the price were historically distant from its moving averages, statistical probability could favor a return to the mean, whereas proximity would suggest continued adherence to the prevailing trend. The current market positioning does not inherently dictate a specific trajectory but rather highlights the need to compare this absolute figure against dynamic average lines to gauge volatility and potential reversal zones accurately. Ultimately, the technical picture relies heavily on the relationship between $60.94 and unprovided moving average figures to assess future behavior. Investors analyzing relative value must determine if this price level reflects a temporary anomaly or a sustained trend by examining where it sits within its own historical distribution envelope. Such an analysis allows for

RSI (14)
SMA 50
SMA 200

Quant Health Deep Dive

5/9
Piotroski F-Score
Average — mixed operational signals
3.5
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.49
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

65.5%
Gross Margin
9.2%
Net Margin
4.7%
ROIC
10.3%
WACC
ROIC − WACC Spread: -5.7%— Negative spread.
+5.1%
Revenue Growth (YoY)
-4.4%
Earnings Growth (YoY)
433.7M
Free Cash Flow

DuPont Analysis — ROE Decomposition

Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.

9.2%
Net Profit Margin
NI ÷ Revenue
×
0.33x
Asset Turnover
Revenue ÷ Assets
×
1.50x
Equity Multiplier
Assets ÷ Equity
=
4.5%
Return on Equity
Balanced ROE composition across margins, turnover, and leverage.

Balance Sheet Health

0.50x
Debt / Equity
1.89x
Current Ratio
6.7x
Interest Coverage
2.2x
Net Debt / EBITDA
2.67%
FCF Yield
1.0B
EBITDA

Earnings Surprise History

Q4
✓ Beat
Est: $0.93
Act: $0.96
+3.3%
Q3
✓ Beat
Est: $1.07
Act: $1.10
+3.0%
Q2
✓ Beat
Est: $1.11
Act: $1.15
+3.3%
Q1
✓ Beat
Est: $1.03
Act: $1.10
+7.1%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Dividend History

$0.0075
Latest Dividend
$0.01
2023 Total
0.0%
YoY Growth
Annual Dividends per Share
$0.01
2003
$0.01
2004
$0.01
2005
$0.01
2006
$0.01
2007
$0.01
2008
$0.01
2009
$0.01
2010
$0.01
2011
$0.01
2012
$0.01
2013
$0.01
2014
$0.01
2015
$0.01
2016
$0.01
2017
$0.01
2018
$0.01
2019
$0.01
2020
$0.01
2021
$0.01
2022
$0.01
2023
DateAmountChange
2023-07-26$0.00750.0%
2023-01-20$0.00750.0%
2022-07-26$0.00750.0%
2022-01-20$0.00750.0%
2021-07-26$0.00750.0%
2021-01-21$0.00750.0%
2020-07-22$0.00750.0%
2020-01-22$0.00750.0%
2019-07-22$0.00750.0%
2019-01-18$0.00750.0%
2018-07-20$0.00750.0%
2018-01-22$0.00750.0%
Stock Splits
2024-02-20: 4:12002-11-25: 2:11995-09-22: 0.333333:1

Dividend and split data from SEC filings and market data. Amounts are per share, not adjusted for splits. Source: yfinance.

Risk Profile

34.3%
Annual Volatility
-0.23
Sharpe (1Y)
-24.3%
Max Drawdown (5Y)

Sharpe = risk-adjusted return (higher is better). Max drawdown = largest peak-to-trough decline. 1,200+ trading days.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fama-French 5-Factor Exposure

Academic factor model decomposition — what's really driving this stock's returns.

0.84
Market β
Mkt-RF
+0.649
Size (SMB)
Small-cap tilt
+0.096
Value (HML)
Neutral
+0.080
Profit (RMW)
Neutral
+0.995
Invest (CMA)
Conservative
Alpha (annual): -14.39%
R²: 33.0%of variance explained by 5 factors

Fama-French 5-Factor Model. Data: Kenneth French Data Library. Regression over 3 years of daily returns.

Fundamentals

12.2
Forward P/E
1.59
PEG Ratio
1.43
Price/Book
2M
Avg Volume
$89.83
52W High
$58.89
52W Low
2%
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$1.5B
Tracked Passive Exposure
8
ETFs Holding COO
0.04%
Avg Weight in ETFs
$3.8T
Total ETF AUM

When investors buy or sell ETFs like XHE or VBR, the fund manager is mechanically forced to buy or sell COO shares regardless of The Cooper Companies, Inc.'s individual fundamentals. We estimate $1.5B of passive capital is structurally linked to COO through 8 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in The Cooper Companies, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.

COO Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
COOEpicenterVOOETFIVVETFSPYETFLLYLow RiskLLYLow RiskJNJLow RiskJNJLow RiskABBVMed Risk
COO Price Drop (%)0

If The Cooper Companies, Inc. (COO) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ELI LILLY + CO (LLY) as the most exposed collateral stock, sharing 1 ETFs with COO. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 24 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

COO Ownership Dynamics

Passive funds hold 1 in every 7 COO shares, reducing daily market volatility.

Ticker
COO
Total Shares
195M
ETF Lock-Up
15.2%
Display Mode
Total Float Impact
15.2%Locked Float

The Cooper Companies, Inc. (COO) exerts notable gravity on the passive index market, currently representing 1.5% of the XHE (XHE) and 0.3% of the VBR (VBR). Across 26 tracked ETFs, approximately 30M shares (15.2% of float) are held by passive funds and rarely trade on the open market. This level of passive ownership means index rebalances can create outsized volume events.

Float lock-up computed from 26 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

COO Institutional Volume Profile

252-day volume distribution by price level. The Point of Control (POC) marks the price where the most institutional volume transacted — an implicit support/resistance floor.

TICKER
COO
PRICE
$59.49
FLOOR (POC)
$70.50
STRENGTH
High
$60$59.49$61$63$64$66$678%$6910%$70POC 13%$7211%$7410%$75$77$78$80$817%$839%$84$86$88$89
Focus Zone
Point of Control (POC) Support (below price) Resistance (above price) Current Price

The highest-volume price zone for The Cooper Companies, Inc. over the past year sits near $70.50 (13% of 252-day volume). The current price of $59.49 sits 15.6% below the POC — suggesting potential mean-reversion upside if institutional demand reasserts at this level. The highly concentrated volume profile (13% at POC) indicates strong consensus on fair value — institutional participants have repeatedly transacted near this price.

Volume Profile computed from 252 trading days of OHLCV data. Volume allocated to price bins proportionally based on daily high-low range. Not investment advice.

COO Capital Efficiency

How efficiently does The Cooper Companies, Inc. convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$434M
EBITDA
$1.0B
FCF Conversion
42%
Reinvestment Rate
58%
42% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
4.7%
ROIC − WACC Spread
-5.7%

The Cooper Companies, Inc. converts 42% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 58% reinvestment rate signals aggressive capacity expansion. However, the ROIC-WACC spread is negative (-5.7%), suggesting reinvested capital is destroying shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-078$61.12$488.96
2026-05-012$62.90$125.8
2026-04-3085,898$61.34$5.3M
2026-04-278$64.42$515.36
2026-04-23262$66.92$17,533.04
2026-04-22270$67.30$18,171
2026-04-167$70.29$492.03
2026-04-153$71.61$214.83
2026-04-091$71.73$71.73
2026-04-071$70.29$70.29
2026-04-011,178$71.50$84,227
2026-03-31555$69.31$38,467.05
2026-03-2528$70.49$1,973.72
2026-03-241$70.24$70.24
2026-03-2355$69.96$3,847.8
2026-03-201,533$70.71$108,398.43
2026-03-192,978$71.17$211,944.26
2026-03-1636$69.92$2,517.12
2026-03-133$71.52$214.56
2026-03-09404,999$76.55$31.0M
2026-03-061,608$80.20$128,961.6
2026-03-044$83.37$333.48
2026-03-02127$83.67$10,626.09
2026-02-1944$83.40$3,669.6
2026-02-062$80.10$160.2
2026-01-278$80.90$647.2
2026-01-232,911$82.80$241,030.8
2026-01-223,699$82.54$305,315.46
2026-01-214,465$80.61$359,923.65
2026-01-1522$81.69$1,797.18

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Price Correlations

Statistical correlation of daily returns with other stocks. High correlations indicate stocks that move together; negative correlations can offer diversification.

Peer252-Day (1Y)126-Day (6M)Direction
WTGXXNaNNaN
MTD0.4930.577Moderate
VRTPX0.4590.432Moderate
PPG0.4490.509Moderate
HRL0.4470.293Moderate
GEHC0.4440.501Moderate
SWK0.4360.515Moderate
DOV0.4350.480Moderate
NDSN0.4310.578Moderate
DD0.4300.429Moderate

Pearson correlation of daily log returns. 252d ≈ 1 trading year. Computed from price history. Not investment advice.

Compare COO to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: 2026-06-02.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.